Tag: Biotech

Commentary

Biotech and Life Sciences: Q3 2019 Summary

The 2019 Q3 biotech and pharmaceutical transactions were defined by an active M&A market as deal value increased across all categories when compared to the …

Read More
Commentary

Biotech and Life Sciences: Q2 2019 Summary

The 2019 Q2 biotech and pharmaceutical transactions were defined by an active IPO summer market as deal value increased across all categories when compared to …

Read More
White Paper

Deal Analysis: Research Institute Contemplating Acquisition

Background An established, biomedical research facility was looking to enter into an agreement with a hospital organization which would absorb the research institute in exchange …

Read More
White Paper

Strategic Modeling Alternatives for a Clinical Stage Pharmaceutical Company

Background A pharmaceutical company, in the midst of a Phase III clinical trial, was considering a variety of strategic and financing alternatives as it prepared …

Read More
Commentary

Biotech and Life Sciences: Q1 2019 Summary

The 2019 Q1 biotech and pharmaceutical transactions have come to end, and the initial results showcase some stark differences when compared to the first quarter …

Read More
Commentary

Complexities in Biotechnology

Biotechnology companies face unique challenges when it comes to understanding the value of their assets.  During the early stages of development, an extraordinary level of …

Read More